7 pharmaceutical companies to seize the country's first! Qilu, Xinlitai, Zhengda sunny...

Medicine Network January 2nd, a drug "national college entrance examination", 7 pharmaceutical companies took the lead across the bridge7pharmaceutical enterprises through the National ExaminationShenzhen Xinlitai, Zhejiang Huahai, National Pharmaceutical Group to Jun (Shenzhen), Qilu Pharmaceutical (Hainan), Nanjing Zhengda Tianqing, Haizheng Pfizer, Chengdu Pate, with 17 product rules, first through the consistency evaluationand Zhejiang Huahai was the biggest winner with 9 product rules and 6 drugsOn December 29, the State Administration of Food and Drug Administration issued a "Notice on the Publication of Drugs (First Batch) (No173 of 2017) on the publication of drugs evaluated for consistency in the quality and efficacy of generic drugsannouncement announced: In accordance with the Drug Administration Law of the People's Republic of China, the State Council's Opinions on reforming the review and approval system for medical devices
medical devices, the opinions of the General Office of the State Council on the conduct of consistent evaluation of the quality and efficacy of generic drugs, and the announcement on matters related to the consistent evaluation of the quality and efficacy of generic drugshas been reviewed and a catalogue of drug application varieties that meet the requirements for consistent evaluation of the quality and efficacy of generic drugs is issued(pictured), the first to pass, exclusiveon March 5, 2016 issued the "State Council Office on the implementation of the quality and efficacy of similar drugs consistent evaluation of the opinion", sounded the warning gunthe General Administration ofin the "on the quality and efficacy of similar drug consistency evaluation of matters related to the announcement" clearly, the same varieties of drugs through consistency evaluation of the productionenterprises reached more than 3, in the centralized procurement of drugs and other aspects of the non-conformity evaluation of varieties The approved drugs are also allowed to be identified as "by consistency evaluation" in drug labels and instructions the centralized procurement of drugs, product appearance has a unique logo Take the lead through, first enjoy the "mountain high man-made peak" pleasure, taste the first mouthful of mandarin, to meet the attention of all the people Congratulations to the seven pharmaceutical companies, 17 drug the strength, to promote sales of more than 10 billion According to minet data, the above products, in 2016 in China's urban public hospital sand , county-level public hospitals, urban community centers, township health hospital terminals and China's urban retail pharmacy terminals, the total sales of more than 10 billion products have 1, for the sulphate chlorpyrifos tablets and total sales of more than 1 billion yuan of products also include hydrochloric acid paroxetine tablets, cephalosporine tablets, giferitintablets, ebesatan hydrochlorpyrifos tablets, reshubatin calcium tablets, ebeshatan tablets, and chlorsatan potassium tablets , The new tablets of Guomedicine to Jundali became the first cephalosporine antibiotics in the country to pass the consistency evaluation, which is also the first variety of enterprises owned by the China Pharmaceutical Group of state-owned enterprises to pass the consistency evaluation public data show that Dudley new (cephalosporine tablets) sample hospital market and retail market share, products have entered the European Union and other mainstream markets, the establishment of international brands this time through consistency evaluation, or will drive a bigger breakthrough in sales of these products